부산대학교 도서관

Gastroesophageal reflux disease (GERD) is a common disorder, known to affect about 20% of the Western population. Although conventional medical or surgical treatment has proven effective, there is certainly room for improvements. As only 10% of GERD patients are finally treated by antireflux surgery, a large therapeutic window exists. This treatment gap consists of patients who are not effectively treated with proton pump inhibitor but do not want to run the potential risks of conventional surgery. During the last two decades, several novel and intriguing options for the surgical treatment of GERD have been introduced and found their way into clinical use. The following summary will give an update of certain alternative therapeutic options to treat GERD or its pathological consequences. Gastroesophageal reflux disease (GERD) is a common disorder, known to affect about 20% of the Western population. Although symptomatic therapy with proton pump inhibitors (PPI) or causative therapy by conventional anti‐reflux surgery has been shown to be effective there is certainly room for improvements. The following summary will give an update of certain alternative therapeutic options to treat GERD or its pathological consequences. [ABSTRACT FROM AUTHOR]